Ketoamides with cyclic P4'S as inhibitors of NS3 protease of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S300000, C514S387000, C514S323000, C514S230800, C514S309000, C514S389000, C548S319500, C548S465000, C548S455000, C546S113000, C546S201000, C546S142000, C544S143000

Reexamination Certificate

active

11065647

ABSTRACT:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

REFERENCES:
patent: 4461293 (1984-07-01), Chen
patent: 2005/0085242 (2005-04-01), Nishizawa
patent: 2005/0085275 (2005-04-01), Hugunin
patent: 2005/0197301 (2005-09-01), Njoroge et al.
patent: 2005/0209164 (2005-09-01), Bogen et al.
patent: WO 02/08244 (2002-01-01), None
patent: WO 03/062265 (2003-07-01), None
patent: WO 03/064456 (2003-08-01), None
Marchetti et al., Synlett, S1, pp. 1000-1002(1999).
International Search Report for PCT/US2005/005924—3 Pages.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ketoamides with cyclic P4'S as inhibitors of NS3 protease of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ketoamides with cyclic P4'S as inhibitors of NS3 protease of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketoamides with cyclic P4'S as inhibitors of NS3 protease of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3847848

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.